NOBELPROCERA: payments to doctors
Payments that named NOBELPROCERA as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.1M
- Providers
- 4,220
- Transactions
- 8,712
- Average per transaction
- $245
The per-transaction average — $245 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,220 providers the average total is $506, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Nobel Biocare USA | $2,135,022 | 99.9% |
| Envista Holdings Corporation | $1,852 | 0.1% |
| Kerr Corporation | $256 | 0.0% |
| Kavo Dental Technologies LLC | $92 | 0.0% |
| Implant Direct Sybron International LLC | $72 | 0.0% |